Baricitinib Is First Approved COVID-19 Immunomodulatory Treatment. Rubin R. JAMA 2022;327:2281.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Rubin R. Baricitinib Is First Approved COVID-19 Immunomodulatory Treatment. JAMA 2022;327:2281.
PMID: 35727290